Immatics N.V. 4

Peter Alan Chambre received an option award for 48,000 Immatics N.V. ordinary shares at a $9.09 exercise price as equity compensation.

On June 16, 2026, reporting person Peter Alan Chambre, an insider of Immatics N.V., received a grant of stock options for 48,000 ordinary shares at an exercise price of $9.09 per share, vesting 100% on the first anniversary of the grant date and expiring on June 15, 2036; immediately upon grant, these options represented 48,000 derivative securities held directly, corresponding to 48,000 underlying ordinary shares. This appears to be a standard equity compensation award rather than an open-market purchase or sale, with no shares bought or sold for cash at the time of the filing.

Filing Facts

CIK

1809196

Ticker

IMTX

Form

4

Source Type

fda

Accession

0000950103-26-009239

Alert Tier

5